Lupus nephritis outcome with and without renal biopsy: A 5-year comparative study

Journal of Clinical Rheumatology

Volumn 10, Issue 6, 2004, Pages 289-294

  Jakez Ocampo, Juan ^a   Arreola Zavala, Ricardo ^a   Richaud Patin, Yvonne ^a   Romero Díaz, Juanita ^a   Llorente, Luis ^a  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

Author keywords

Lupus nephritis; Prognosis; Renal biopsy

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE; PREDNISONE;

ADOLESCENT; ADULT; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; GLOMERULONEPHRITIS; HISTOLOGY; HUMAN; KIDNEY BIOPSY; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY FUNCTION TEST; LABORATORY TEST; LUPUS ERYTHEMATOSUS NEPHRITIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEINURIA; SURVIVAL; TREATMENT OUTCOME;

EID: 10044228298     PISSN: 10761608     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.rhu.0000147046.78645.60     Document Type: Article

References (31)

1. Wallace DJ, Hahn BH, Klippel JH. Lupus nephritis. In: Wallace DJ, Hahn BH, eds. Dubois' Lupus Erythematosus. Baltimore: Williams & Wilkins; 1997:1053-1065.
2. Esdaile JM, Mackenzie T, Barré P, et al. Can experienced clinicians predict the outcome of lupus nephritis? Lupus. 1992;1:205-214.
3. Rojas C, Jacobelli S, Massardo L, et al. Disseminated lupus erythematosus without abnormalities in urinary sediment. Rev Med Chile. 1987;115:120-125.
4. Klippel JH. How to alter the course of lupus nephritis. J Musculoskeletal Dis. 1988;5:29-43.
5. Font J, Torras A, Cervera R, et al. Silent renal disease in systemic lupus erythematosus. Clin Nephrol. 1987;27:283-288.
6. Pirani CL, Salinas-Madrigal L. Evaluation of percutaneous renal biopsies. In: Sommers SC, ed. Pathology Annual. New York: Appleton-Century-Crofts Inc; 1968:249-254.
7. Austin H, Muenz L, Joyce K, et al. Prognostic factors in lupus nephritis: contribution of renal histologic data. Am J Med. 1983;75:382-391.
8. Wernick RM, Smith DL, Houghton DC, et al. Reliability of histologic scoring for lupus nephritis: a community-based evaluation. Ann Intern Med. 1993;119:805-811.
9. Wallace DJ, Podell TE, Weiner JM, et al. Lupus nephritis. Experience with 230 patients in a private practice from 1950 to 1980. Am J Med. 1992;72:209-220.
10. Wallace DJ, Podell T, Weiner J, et al. Systemic lupus erythematosus - survival patterns. Experience with 609 patients. JAMA. 1981;245:934-938.
11. Pristiner M, Wallace DJ, Nessim S, et al. Lupus erythematosus in the 1980s: a survey of 570 patients. Semin Arthritis Rheum. 1991;21:55-64.
12. Gamba G, Reyes E, Angeles A, et al. Observer agreement in the scoring of the activity and chronicity indexes of lupus nephritis. Nephron. 1991;57:75-77.
13. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematous. Arthritis Rheum. 1982;25:1271-1277.
14. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39(suppl 1):S1-266.
15. Neumann K, Wallace DJ, Azen C, et al. Lupus in the 1980s: III. Influence of clinical variables, biopsy and treatment on the outcome in 150 patients with lupus nephritis seen at a single center. Semin Arthritis Rheum. 1995;25:47-55.
16. Rosner S, Ginzler EM, Diamond HS, et al. A multicenter study of outcome in systemic lupus erythematosus. II. Causes of death. Arthritis Rheum. 1982;25:612-617.
17. Cheigh JS, Stenzel KH. End-stage renal disease in systemic lupus erythematosus. Am J Kidney Dis. 1993;21:2-8.
18. Derksen RHWM, Hené RJ, Kater L. The long-term clinical outcome of 56 patients with biopsy proven lupus nephritis followed at a single center. Lupus. 1992;1:97-103.
19. Ballow JE, Austin HA, Tsokos GC, et al. Lupus nephritis. NIH conference. Ann Intern Med. 1987;106:79-94.
20. Karsh J, Klippel JH, Balow JE, et al. Mortality in lupus nephritis. Arthritis Rheum. 1979;22:764-769.
21. Esdaile JM, Abrahamowicz M, MacKenzie T, et al. The time dependence of long-term prediction in lupus nephritis. Arthritis Rheum. 1994;37:359-368.
22. Levey AS, Lan SP, Corwin HL, et al. Progression and remission of renal disease in the Lupus Nephritis Collaborative Study. Results of treatment with prednisone and short-term oral cyclophosphamide. Ann Intern Med. 1992;116:114-123.
23. Ginzler EM, Diamond HS, Weiner M, et al. A multicenter study of outcome in systemic lupus erythematosus. I. Entry variables as predictors of progress. Arthritis Rheum. 1982;25:601-611.
24. Abu-Shakra M, Urowitz MB, Gladman DD, et al. Mortality studies in systemic lupus erythematosus. Results from a single center. I. Causes of death. J Rheumatol. 1995;22:1259-1264.
25. Gladman DD, Urowitz MB, Cole E. Kidney biopsy in SLE. I. A clinical-morphologic evaluation. Q J Med. 1989;73:1125-1133.
26. Nossent HC, Henzen-Logmans SC, Vroom TM. Contribution of renal biopsy data in predicting outcome in lupus nephritis. Arthritis Rheum. 1990;33:970-977.
27. Whiting-O'Keefe Q, Riccardi PJ, Henke JE, et al. Recognition of information in renal biopsies of patients with lupus nephritis. Ann Intern Med. 1982;96:723-727.
28. Felson DT, Anderson JJ. Evidence for the superiority of immunosuppressive drugs and prednisone over prednisone alone in lupus nephritis: results of a pooled analysis. N Engl J Med. 1984;311:1528-1533.
29. Steinberg AD, Steinberg SC. Long-term preservation of renal function in patients with lupus receiving treatment that includes cyclophosphamide versus those treated with prednisone only. Arthritis Rheum. 1991;34:945-950.
30. Boumpas DT, Austin HA, Vaughn EM, et al. Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritis. Lancet. 1992;340:741-745.
31. Gourley MF, Austin HA, Scott D, et al. Methylprednisolone and cyclophosphamide, alone or in combination, in patients with lupus nephritis. A randomized controlled trial. Ann Intern Med. 1996;125:549-557.